Search

Your search keyword '"Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany]"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany]" Remove constraint Author: "Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany]"
22 results on '"Zentrum für Rhinologie und Allergologie [Wiesbaden, Germany]"'

Search Results

1. COVID-19 pandemic

2. Pollen season is reflected on symptom load for grass and birch pollen‐induced allergic rhinitis in different geographic areas—An EAACI Task Force Report

3. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases -Meeting Report (Part 1)

4. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

5. Therapy of allergic rhinitis in routine care: evidence-based benefit assessment of freely combined use of various active ingredients

6. Therapy of allergic rhinitis in routine care: evidence-based benefit assessment of freely combined use of various active ingredients: A position paper of the Medical Association of German Allergists (AEDA) in cooperation with the ENT section of the European Academy of Allergy and Clinical Immunology (EAACI), the German ARIA (Allergic Rhinitis and its Impact on Asthma) Group and the Working Group Clinical Immunology, Allergology and Environmental Medicine of the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC)

7. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic:Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)

8. Spices to Control COVID-19 Symptoms: Yes, but Not Only…

9. Position paper: Suggestions for patient information and education before application of biologics in chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations of the Medical Association of German Allergologists (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC) - Part 1: Dupilumab

10. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu

11. Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence

12. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.

13. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.

14. Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey.

15. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.

17. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.

18. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.

19. Accelerated Dose Escalation with Three Injections of an Aluminum Hydroxide-Adsorbed Allergoid Preparation of Six Grasses Is Safe for Patients with Moderate to Severe Allergic Rhinitis.

20. Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy.

21. Is The Allergen Really Needed in Allergy Immunotherapy?

22. Early detection of allergic diseases in otorhinolaryngology.

Catalog

Books, media, physical & digital resources